Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | MMP1 | P03956 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 1/20 | 0.44 |
| ▸ | MMP9 | P14780 | 1/20 | 0.44 |
| ▸ | MMP8 | P22894 | 1/20 | 0.44 |
| ▸ | MMP13 | P45452 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA3 | P07451 | 1/20 | 0.43 |
| ▸ | CA6 | P23280 | 1/20 | 0.43 |
| ▸ | CA5A | P35218 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2576334 | 0.92 | GAA (0.54) | GAASMN1; SMN2ALDH1A1CA1CA2 | |
| Ammonia Solution, Strong SCHEMBL5934814 | 0.90 | GAA (0.52) | GAASMN1; SMN2ALDH1A1CA1CA2 | |
| Ethylene Glycol SCHEMBL3283790 | 0.77 | GAA (0.52) | GAASMN1; SMN2RECQLALDH1A1CA1 | |
| Ethylene Glycol SCHEMBL6046435 | 0.77 | GAA (0.52) | GAASMN1; SMN2RECQLALDH1A1CA1 | |
| Ethylene Glycol SCHEMBL1617251 | 0.77 | GAA (0.52) | GAASMN1; SMN2RECQLALDH1A1CA1 | |
| Ethylene Glycol SCHEMBL6046494 | 0.77 | GAA (0.52) | GAASMN1; SMN2RECQLALDH1A1CA1 | |
| Ethylene Glycol SCHEMBL1936216 | 0.77 | GAA (0.52) | GAASMN1; SMN2RECQLALDH1A1CA1 | |
| Ethylene Glycol SCHEMBL1617625 | 0.77 | GAA (0.52) | GAASMN1; SMN2RECQLALDH1A1CA1 | |
| Ethylene Glycol SCHEMBL241885 | 0.77 | GAA (0.52) | GAASMN1; SMN2RECQLALDH1A1CA1 | |
| Ethylene Glycol SCHEMBL1247518 | 0.77 | GAA (0.52) | GAASMN1; SMN2RECQLALDH1A1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12577371-B2 | Oxidatively curable coating composition | MILLIKEN INDUSTRIALS LIMITED (GB) | 2026-03-17 | — | — | US | disclosed |
| EP-3818115-B1 | OXIDATIVELY CURABLE COATING COMPOSITION | MILLIKEN INDUSTRIALS LTD (GB) | 2023-11-22 | — | — | EP | disclosed |
| US-20210221975-A1 | OXIDATIVELY CURABLE COATING COMPOSITION | Borchers Catalyst (UK) Limited (GB) | 2021-07-22 | — | — | US | disclosed |
| EP-3818115-A1 | OXIDATIVELY CURABLE COATING COMPOSITION | Borchers Catalyst (UK) Limited (GB) | 2021-05-12 | — | — | EP | disclosed |
| WO-2020008204-A1 | OXIDATIVELY CURABLE COATING COMPOSITION | CATEXEL LIMITED (GB) | 2020-01-09 | — | — | WO | disclosed |
| US-8945514-B2 | Contrast agents for magnetic resonance imaging | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2015-02-03 | — | — | US | disclosed |
| US-20070218010-A1 | Contrast Agents for Magnetic Resonance Imaging | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2007-09-20 | — | — | US | disclosed |
| US-4639365-A | Gadolinium chelates as NMR contrast agents | THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1987-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577371-B2 | Oxidatively curable coating composition | TET1, JMJD6, SETDB1 | GAA 2687/4885SMN1; SMN2 1213/4885RECQL 3370/4885 |
| US-20070218010-A1 | Contrast Agents for Magnetic Resonance Imaging | MAG, SLC40A1, FABP7 | GAA 644/4885SMN1; SMN2 877/4885RECQL 3512/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.